JPS6196999A - Method of testing sensitivity of bacteria to medicine - Google Patents

Method of testing sensitivity of bacteria to medicine

Info

Publication number
JPS6196999A
JPS6196999A JP22003384A JP22003384A JPS6196999A JP S6196999 A JPS6196999 A JP S6196999A JP 22003384 A JP22003384 A JP 22003384A JP 22003384 A JP22003384 A JP 22003384A JP S6196999 A JPS6196999 A JP S6196999A
Authority
JP
Japan
Prior art keywords
bacterial
cultivation
tubes
reaction material
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP22003384A
Other languages
Japanese (ja)
Other versions
JPH0527397B2 (en
Inventor
Toshiyuki Kitagawa
俊之 北川
Kenji Asano
健治 浅野
Kenkichi Nishimura
西村 健吉
Kazuyuki Sugawara
和行 菅原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Kobayashi Seiyaku KK
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Kobayashi Seiyaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd, Kobayashi Seiyaku KK filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP22003384A priority Critical patent/JPS6196999A/en
Publication of JPS6196999A publication Critical patent/JPS6196999A/en
Publication of JPH0527397B2 publication Critical patent/JPH0527397B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:A series of cultivation tubes is arranged in rows and filled with a culture medium containing a medicine whose concentration is diluted in a certain step in a series and the tubes are covered with a sheet to which a reaction material is set to places corresponding to individual cultivation tubes, then, the whole body is turned upside and down, when the reaction is over, to detect the growth of a microorganism by the change in color of the reaction material. CONSTITUTION:As shown in the figure, a series of tubes for cultivation 3 are set in rows, e.g., to a perforated plate 1 and an impermeating sheet 8, to which a reaction material containing an indication reagent or coloring reagent for the substrate or the product therefrom is sticked on the places corresponding to individual cultivation tubes 3, is bonded to the perforated plate 1. For example, a culture medium containing an antibiotic is placed in the cultivation tubes 3, a microorganism is inoculated to the medium, then cultivation is effected. After cultivation for a certain period, the sheet 8 is peeled off to observe the color change of the reaction material 7 to determine the MIC of the antibiotic.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、感染症の化学療法を行うにあたって、有効な
薬剤の選択またはその薬剤の抗菌力を知るための細菌の
薬剤感受性検査方法に関するものである。
[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a method for testing the drug susceptibility of bacteria to select an effective drug or to determine the antibacterial activity of the drug when conducting chemotherapy for infectious diseases. It is.

〔従来の技術〕[Conventional technology]

一般に細菌の薬剤感受性検査方法は、希釈法と拡散法に
大別されるが通常薬剤の最小発育阻止濃度(Minim
um Inhibitory Concentrati
on ; MIC)を求める方法としては、希釈法が用
いられる。希釈法には寒天平板希釈法と液体培地希釈法
とがあり、いずれも薬剤を一定濃度段階で含有する培地
に、被検菌液を接種し、一定時間培養後、判定を行う。
In general, bacterial drug susceptibility testing methods are broadly divided into dilution methods and diffusion methods, but usually the minimum inhibitory concentration (Minimum Inhibitory Concentration) of the drug is
um Inhibitory Concentrati
on ; MIC) is determined by a dilution method. Dilution methods include the agar plate dilution method and the liquid medium dilution method. In both cases, a test bacterial solution is inoculated into a medium containing a drug at a certain concentration level, and after culturing for a certain period of time, a determination is made.

従来、試験管またはシャーレ等で行われている判定は、
培地上に発生した菌の集落の数、性状まIこは培地表面
の色の対比、濁度など、菌の発育そのものを目安にした
もので、対照培地との比較において、多数の試験管、シ
ャーレ等の観察が必要とされ、またある種の判定表を用
いるなど、およそ簡易な操作とは言い難く試験結果に誤
りが生じる場合もある。また近年開発された液体培地を
使用する薬剤感受性測定機械は、成域本体が高価である
ばかりでなく、その操作法も未だ半自動化の域をでてお
らず、結局煩雑な操作を必要としているのが現状である
Conventionally, determinations are made using test tubes or petri dishes.
The number and properties of bacterial colonies that have developed on the medium are based on the bacterial growth itself, such as the color contrast and turbidity of the medium surface.In comparison with the control medium, a large number of test tubes, The test requires observation of petri dishes, etc., and uses a certain type of evaluation table, which is far from a simple operation and may lead to errors in the test results. Furthermore, drug susceptibility measuring machines that have been developed in recent years that use liquid media are not only expensive, but their operating methods are still only semi-automated, and ultimately require complicated operations. is the current situation.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明は、上記従来の薬剤感受性試験の判定における欠
点を伴うことなく、細菌の発育を簡単な操作で正確に判
定できようにした細菌の薬剤感受性検査方法を提供する
ものである。
The present invention provides a method for testing the drug susceptibility of bacteria, which allows the growth of bacteria to be accurately determined with simple operations without the drawbacks of the conventional drug susceptibility tests described above.

〔問題点を解決するための手段〕[Means for solving problems]

現在、細菌の固定に関しては、多種生化学性状を基盤と
して菌種の同定が行われている。主に酵素反応が中心で
あるが、基質と指示薬の組み合せた培地等に菌を接種し
、その色調の変化でもって陽性、陰性を判定し、十数項
目にわたる性状について調べ、解析表等によって種レベ
ルまでの同定が行われている。
Currently, when fixing bacteria, bacterial species are identified based on various biochemical properties. Although mainly enzymatic reactions are involved, bacteria are inoculated into a medium containing a combination of a substrate and an indicator, positive or negative is determined by the change in color, and the properties are examined in more than 10 items. Identification up to this level has been carried out.

本発明は、この同定理論に着目し、細菌の薬剤感受性検
査における判定、つまり細菌の発育確認を同細菌の有す
るある種の基質に対する反応、すなわち、細面の発育に
伴う酵素活性の増大を指標として簡便化、正確化をはか
り、かつ廉価で供給しようとするものである。その具体
的手段としては、細菌培養容器の培養槽に薬剤を一定の
希釈系列で含有させた培地を充堺し、被検菌の接種前又
は培養後に細菌の発育の指標となる基質を添加し、一定
時間反応後、容器を転倒させることにより、基質又は基
質分解生成物に対する指示薬ないし発色剤を含有してい
る反応材にて、細菌の発育の有無を色調の変化で検出す
るようにしている。
The present invention focuses on this identification theory, and uses the reaction of the bacteria to a certain type of substrate, that is, the increase in enzyme activity associated with the growth of small surfaces, as an indicator for making judgments in bacterial drug susceptibility tests, that is, confirming the growth of bacteria. The aim is to simplify, increase accuracy, and provide it at a low price. A specific method for this is to fill the culture tank of a bacterial culture container with a medium containing a certain dilution series of drugs, and add a substrate that is an indicator of bacterial growth before or after inoculating the test bacteria. After a certain period of reaction, by inverting the container, the presence or absence of bacterial growth can be detected by a change in color using a reaction material containing an indicator or coloring agent for the substrate or substrate decomposition products. .

前記基質としては、アドニトール、アラビノース、アミ
ダブリ・ン、セロビオース、ダルシミトール、フラクト
ース、グリセロール、グリコーゲン、α−メチルグリコ
サイド、N−アセチルグリコサミン、2−ケトーD−グ
ルコニックアシッド、ガラクトース、イノシトール、イ
ヌリン、ラクトース、マルトース、マンニトール、マン
ノース、メリビオース、フラクトース、ラフィノース、
リボース、サリシン、ソルビトール、スターチ、シュー
クロース、トレハロース、ツラノース、キシロース、キ
シリット、アルギニン、エスクリン、ゼラチン、6−B
r−2ナフチルα−Dガラクトピラノサイド、2−ナフ
チルβ−Dガラクトピラノサイド、ナフトールMS−B
Iβ−Dグルクロネート、ヒソプレート、リジン、L−
ロイシル2−ナフチルアミド、オルトニトロフェニール
−β−D−ガラクトピラノシド、2−ナフチルフォスフ
ェート、尿素、過酸化水素、クエン酸塩、マロン酸塩、
硝酸塩、ピルビン酸塩、トリプトファン、ペプトン、チ
オサルフェート、テトラゾリウム各種誘導体、4メチル
ウンベリフ工リル各種誘導体などがあげられる。
The substrates include adonitol, arabinose, amidabrine, cellobiose, dulcimitol, fructose, glycerol, glycogen, α-methyl glycoside, N-acetyl glycosamine, 2-keto D-gluconic acid, galactose, inositol, inulin, Lactose, maltose, mannitol, mannose, melibiose, fructose, raffinose,
Ribose, salicin, sorbitol, starch, sucrose, trehalose, turanose, xylose, xylit, arginine, esculin, gelatin, 6-B
r-2 naphthyl α-D galactopyranoside, 2-naphthyl β-D galactopyranoside, naphthol MS-B
Iβ-D glucuronate, hisoplate, lysine, L-
leucyl 2-naphthylamide, orthonitrophenyl-β-D-galactopyranoside, 2-naphthyl phosphate, urea, hydrogen peroxide, citrate, malonate,
Examples include nitrate, pyruvate, tryptophan, peptone, thiosulfate, various tetrazolium derivatives, and various 4-methylumbelliferyl derivatives.

また反応材にあらかじめ含有させて用いる指示薬ないし
発色剤としては、フェノールレッド、ブロムチモールブ
ルー、ブロムクレゾールパープル、メチルバイオレット
、チモールブルー、ニュートラルレッド、クロルフェノ
ールレッド、クレゾールレッド、フェノールフタレイン
、レサズリン、ニンヒドリン試薬、塩化第二鉄、バラア
ミノジエチルアニリン、スルファニール酸、α−ナフチ
ルアミン、塩化カリウム、α−ナフトール、コハソク試
薬などがあげられる。
Indicators or coloring agents that are pre-contained in the reaction material include phenol red, bromothymol blue, bromcresol purple, methyl violet, thymol blue, neutral red, chlorophenol red, cresol red, phenolphthalein, resazurin, and ninhydrin. Examples include reagents such as ferric chloride, baraminodiethylaniline, sulfanilic acid, α-naphthylamine, potassium chloride, α-naphthol, and Kohasoku's reagent.

〔作用〕[Effect]

上記手段を施した結果、本発明の薬剤感受性検査方法で
は、腸内細菌科をはじめ、結核菌、真菌など、通常臨床
m凹検査室で取り扱われるすべての菌種について、その
発育を簡単な操作で正確に判定できるようになった。
As a result of implementing the above measures, the drug susceptibility testing method of the present invention allows the growth of all bacterial species that are normally handled in clinical laboratories, including Enterobacteriaceae, Mycobacterium tuberculosis, and fungi, to be easily performed. It is now possible to make accurate judgments.

〔実施例〕〔Example〕

以下、本発明の構成を実施例に従い詳述する。 Hereinafter, the configuration of the present invention will be explained in detail according to examples.

実施例では、第1図に示したような、容器本体(1)の
長手方向の一方側部に上部が互いに連通した複数の菌液
接種槽(2)を設け、他方側部に各々が独立した複数の
培#槽(3)を設け、これら菌液接種槽(2)と培養槽
(3)とを、起伏通路(4)により連通し、さらに前記
培養槽(3)の上方に当る位置に小孔(5)を設けた被
覆フィルム(6)を前記容器本体(1)の上面に貼着す
ると共に、この被覆フィルム(6)に設けた小孔(5)
を塞ぐようにして被覆フィルム(6)の上面に、基質又
は基質分解生成物に対する指示薬ないし発色剤を含有し
ている反応材(7)を連設したテープ(8)を貼着した
細菌検査用培養容器であるとか、第2図に示したような
、容器本体(1)に多数の培養槽(3)を複数列並設し
、これら培養i!I(3)の上方に当る位置に、基質又
は基質分解生成物に対する指示薬ないし発色剤を含有し
ている反応材(7)を連設したテープ(8)を複数列貼
着した細菌検査用培養容器を用いて本発明の検査方法を
実施した。
In the example, as shown in FIG. 1, a plurality of bacterial liquid inoculation tanks (2) whose upper parts communicate with each other are provided on one longitudinal side of a container body (1), and each is independent on the other side. A plurality of culture tanks (3) are provided, and these bacterial solution inoculation tanks (2) and culture tanks (3) are communicated by an undulating passageway (4), and a position above the culture tank (3) is provided. A covering film (6) with small holes (5) provided therein is pasted on the top surface of the container body (1), and the small holes (5) provided in this covering film (6) are attached to the upper surface of the container body (1).
For bacterial testing, a tape (8) with a reactive material (7) containing an indicator or coloring agent for the substrate or substrate decomposition products is attached to the top surface of the coating film (6) so as to cover the substrate. A culture container, as shown in FIG. 2, is a container body (1) with a large number of culture tanks (3) arranged in multiple rows, and these culture i! A culture for bacterial testing in which multiple rows of tape (8) each containing a reaction material (7) containing an indicator or a coloring agent for the substrate or substrate decomposition product are pasted above I (3). The testing method of the present invention was carried out using the container.

そこで、液体培地希釈法を使用した薬剤感受性検査方法
について、臨床分離結核菌10株を対象に抗結核薬のM
ICIC窓を行った。抗結核薬としては、リファンピシ
ン、カナマイシン、イソニアシト、ストレプトマイシン
の4種類で、前記細菌検査用培養容器の培養槽(3)に
5v!づつ、菌液接種後濃度として10吻/−J’ 、
5し//%/、2%/ジ、12.火々、6.25/ly
々、3.1に、々、1.5624り/、、/ 、 0.
7号、(メツ1−)?、 0.3Qンーメ/づ一ン一、
 0.29.へ〆/1−lピ、0.1o/14/JT、
 Olの12/度となるようMiddle br。
Therefore, regarding the drug susceptibility testing method using the liquid medium dilution method, we tested 10 strains of clinically isolated Mycobacterium tuberculosis.
I did an ICIC window. There are four types of anti-tuberculosis drugs: rifampicin, kanamycin, isoniacyto, and streptomycin, and 5V! Each time, the concentration after inoculating the bacterial solution was 10/-J',
5shi//%/, 2%/di, 12. Fire, 6.25/ly
3.1, 1.5624 ri/,,/, 0.
No. 7, (Metsu 1-)? , 0.3Qnme/zuinichi,
0.29. To〆/1-l pi, 0.1o/14/JT,
Middle br so that it is 12/degrees of Ol.

ok7H9液体培地で調整した。また比較対照法として
は、市販の上記薬剤含有の1%小川培地を使用した。接
種は、マンクファーランド0.2に調整した菌液を液体
培地希釈法では培養槽(3)に50/、前記薬剤含有1
%小川培地には1oo/A/!流し込み、培養期間は、
37℃で液体培地希釈法では1o日間、薬剤含有1%小
川培地では3週間とした。判定は、薬剤含有1%小川培
地では従来の集落の発生、数、性状より感受性、耐性を
+、−で表わし、また液体培地希釈法では本発明による
方法を用いた。この場合の検出法では、結核菌の有する
硝酸塩還元能をみたもので基質としては、M150硝酸
ナトリウム液を判定日当口、各培養槽(3)に1007
Jづつ加え37℃で2時間放置後、容器本体(1)を転
倒させ、発色剤を含んだ反応材(7)上の赤紫色の発現
で発育の有無を観察しMIC値を求めた。前記反応材(
7)としては、スルファニル酸2g、N−1ナフチル工
チレンジアミン2g、酒石酸20gをlOO〜どの蒸留
水に溶解させた液30メを、直径8鰭のディスクに含浸
させ風乾させたものを用いた。
Adjusted with ok7H9 liquid medium. As a comparative method, a commercially available 1% Ogawa medium containing the above drug was used. Inoculation is carried out using the liquid medium dilution method, in which a bacterial solution adjusted to 0.2 Munck-Farland is added to the culture tank (3) at a concentration of 50% and the above-mentioned drug-containing 1.
% Ogawa medium is 1oo/A/! The pouring and culturing period is
It was kept at 37°C for 10 days in the liquid medium dilution method, and for 3 weeks in the drug-containing 1% Ogawa medium. For judgment, sensitivity and resistance were expressed as + and - based on the occurrence, number, and properties of conventional colonies in the 1% Ogawa medium containing drugs, and the method according to the present invention was used in the liquid medium dilution method. The detection method in this case examines the nitrate-reducing ability of Mycobacterium tuberculosis, and as a substrate, M150 sodium nitrate solution is used on the day of determination, and 100% of each culture tank (3) is used.
After adding J in portions and leaving it for 2 hours at 37°C, the container body (1) was overturned, and the presence or absence of growth was observed by the appearance of reddish-purple color on the reaction material (7) containing the coloring agent, and the MIC value was determined. The reaction material (
As for 7), a disk with a diameter of 8 fins was impregnated with 30 ml of a solution in which 2 g of sulfanilic acid, 2 g of N-1 naphthyl engineered ethylene diamine, and 20 g of tartaric acid were dissolved in 100 to 100 ml of distilled water, and then air-dried. .

以上の操作により測定した臨床分離株の本発明の方法に
よるMIC値と薬剤含有1%小川培地による近似MIC
値との比較結果は、表■に示す通りである。
MIC values of clinical isolates measured by the above procedure according to the method of the present invention and approximate MIC using drug-containing 1% Ogawa medium
The results of comparison with the values are shown in Table ■.

(以下余白) 〔発明の効果〕 本発明の細菌の薬剤感受性検査方法は、以上に述べたよ
うに構成されているので、細菌の発育を容器本体を転倒
させることにより、簡単な操作で正確に判定できるもの
であり、優れた効果を有する。
(The following is a blank space) [Effects of the Invention] Since the bacterial drug susceptibility testing method of the present invention is configured as described above, bacterial growth can be accurately detected with a simple operation by inverting the container body. It can be determined and has excellent effects.

尚、本発明は一薬剤については同一の容器に一定の濃度
希釈系列で調整しているので、接種等の操作が容易で正
確なMIC値が得られるという効果を有し、また発育の
確認は、集落の発生ではなく、細菌の生化学性状に基づ
いているので、MIC値の誤判定が少ないという効果を
有する。
In addition, in the present invention, since one drug is prepared in the same container in a constant concentration dilution series, operations such as inoculation are easy and accurate MIC values can be obtained, and growth can be confirmed easily. Since this method is based on the biochemical properties of bacteria rather than on the occurrence of colonies, it has the effect of reducing erroneous determination of MIC values.

さらに、本発明では検出系の指示薬ないし発色剤等を培
地とは別に構成しているので、あらかじめ培地中に混在
されているものと比較して、保存安定性と試薬安定性と
が良好であり、また酵素反応後発色操作を行うので、あ
る種の指示薬ないし発色剤により発育の阻害を受ける性
質を有する細菌の薬剤感受性検査を行うこともできると
いう効果を有する。
Furthermore, in the present invention, since the indicator or coloring agent of the detection system is configured separately from the medium, storage stability and reagent stability are better than those that are mixed in the medium in advance. Furthermore, since the coloring operation is performed after the enzymatic reaction, it has the advantage that it is also possible to perform drug sensitivity tests on bacteria whose growth is inhibited by certain indicators or coloring agents.

また、本発明においては薬剤の一定濃度の希釈系列で行
う本来のMIC値測定用としてだけでなく、種々の抗菌
剤のそれぞれについての一定濃度のもので行うことによ
りスクリーニング用として実施することができ、さらに
は添加基質と発色系の適当な組み合せにより、細菌の同
定用としての機能を有することが可能であるという効果
を有する。
In addition, in the present invention, it can be carried out not only for the original MIC value measurement performed with a dilution series of a constant concentration of a drug, but also for screening purposes by performing with a constant concentration of each of various antibacterial agents. Furthermore, it has the effect that it can have a function for identifying bacteria by appropriately combining an added substrate and a coloring system.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の細菌の薬剤感受性検査方法に用いる細
菌検査用培養容器の一実施例を示す斜視図、第2図はそ
の細菌検査用培養容器の他実施例を示す斜視図である。
FIG. 1 is a perspective view showing one embodiment of the culture container for bacterial testing used in the bacterial drug susceptibility testing method of the present invention, and FIG. 2 is a perspective view showing another embodiment of the culture container for bacterial testing.

Claims (1)

【特許請求の範囲】[Claims] 1、複数の独立した凹状部からなる培養槽の上方に、そ
れぞれ反応材を装着した細菌培養容器を用いて、その培
養槽に薬剤を一定の希釈系列で含有させた培地を充填し
、被検菌の接種前又は培養後に細菌の発育の指標となる
基質を添加し、一定時間反応後、前記細菌培養容器を転
倒させて菌液を反応材に浸漬させることにより、細菌の
発育の有無を反応材の色調の変化で検出することを特徴
とする細菌の薬剤感受性検査方法。
1. Using a bacterial culture container each equipped with a reaction material above a culture tank consisting of a plurality of independent concave portions, fill the culture tank with a medium containing a drug at a certain dilution series, and A substrate serving as an indicator of bacterial growth is added before or after inoculation of bacteria, and after reaction for a certain period of time, the bacterial culture container is overturned to immerse the bacterial liquid in the reaction material to determine the presence or absence of bacterial growth. A bacterial drug susceptibility testing method that detects by detecting changes in the color tone of wood.
JP22003384A 1984-10-18 1984-10-18 Method of testing sensitivity of bacteria to medicine Granted JPS6196999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22003384A JPS6196999A (en) 1984-10-18 1984-10-18 Method of testing sensitivity of bacteria to medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22003384A JPS6196999A (en) 1984-10-18 1984-10-18 Method of testing sensitivity of bacteria to medicine

Publications (2)

Publication Number Publication Date
JPS6196999A true JPS6196999A (en) 1986-05-15
JPH0527397B2 JPH0527397B2 (en) 1993-04-21

Family

ID=16744873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22003384A Granted JPS6196999A (en) 1984-10-18 1984-10-18 Method of testing sensitivity of bacteria to medicine

Country Status (1)

Country Link
JP (1) JPS6196999A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728350A (en) * 1992-08-21 1998-03-17 Showa Yakuhin Kako Co., Ltd. Chemical or microbiological test kit
US5955352A (en) * 1994-12-22 1999-09-21 Showa Yakuhin Kako Co., Ltd. Instruments for chemical and microbiological tests
WO2005047454A1 (en) * 2003-11-13 2005-05-26 Ajinomoto Co., Inc. Plate containing amino acid medium and screening method with the use of plate containing amino acid medium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52154581A (en) * 1976-01-12 1977-12-22 Unilever Nv Stabilization of compound
JPS5332188A (en) * 1976-09-07 1978-03-27 Warner Lambert Co Method and apparatus for diagnosis
JPS5661998A (en) * 1979-10-11 1981-05-27 American Home Prod Microorganism test method and apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52154581A (en) * 1976-01-12 1977-12-22 Unilever Nv Stabilization of compound
JPS5332188A (en) * 1976-09-07 1978-03-27 Warner Lambert Co Method and apparatus for diagnosis
JPS5661998A (en) * 1979-10-11 1981-05-27 American Home Prod Microorganism test method and apparatus

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728350A (en) * 1992-08-21 1998-03-17 Showa Yakuhin Kako Co., Ltd. Chemical or microbiological test kit
US5955352A (en) * 1994-12-22 1999-09-21 Showa Yakuhin Kako Co., Ltd. Instruments for chemical and microbiological tests
WO2005047454A1 (en) * 2003-11-13 2005-05-26 Ajinomoto Co., Inc. Plate containing amino acid medium and screening method with the use of plate containing amino acid medium
JPWO2005047454A1 (en) * 2003-11-13 2007-05-31 味の素株式会社 Plate containing amino acid medium and screening method using plate containing amino acid medium
JP4770463B2 (en) * 2003-11-13 2011-09-14 味の素株式会社 Plate containing amino acid medium and screening method using plate containing amino acid medium

Also Published As

Publication number Publication date
JPH0527397B2 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
King et al. Muramic acid as a measure of microbial biomass in estuarine and marine samples
US4767702A (en) Paper strip assay for neisseria species
US6046021A (en) Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
CA2262923C (en) Article and method for detection of enterotoxigenic staphylococci
US6472201B1 (en) Comparative phenotype analysis
AU672138B2 (en) Method and apparatus for determining the sensitivity of MAI (mycobacterium avium-intracellulare) to different antibiotics and dosages thereof
US5569592A (en) Apparatus for testing MAI (mycobacterium avium-intracellulare) for antimicrobial agent sensitivity
US7087401B2 (en) Culture medium and method for detecting thermonuclease-positive staphylococci
US4390622A (en) Neisseria bacteria species identification and beta lactamase testing methods
EP0025467B1 (en) Chromogenic chemical substrates for identification of microbial colonies
Witebsky et al. Identification of mycobacteria by conventional methods
US3856628A (en) Method and apparatus for the identification of microorganisms
Steed et al. Rapid detection of Streptococcus pyogenes in pediatric patient specimens by DNA probe
Blackall An evaluation of methods for the detection of carbohydrate fermentation in avian Haemophilus species
Bennett et al. Identification of fusobacteria in a routine diagnostic laboratory
US3806422A (en) Screening test apparatus for enzyme activity in blood and biological fluids
JPS6196999A (en) Method of testing sensitivity of bacteria to medicine
Duerden Pigment production by Bacteroides species with reference to sub-classification
Dilnessa et al. Emerging blood culture technologies for isolation of blood pathogens at clinical microbiology laboratories
EP2495331B1 (en) Testing method for drug sensitivity of mycobacterium tuberculosis, application of indicator and solid medium
US3597321A (en) Diagnostic compostion for the differentiation of staphylococci
JPH0526478B2 (en)
Dealler et al. Identification of Neisseria gonorrhoeae using the Neisstrip rapid enzyme detection test.
JPH0526480B2 (en)
EP0175421A2 (en) Test method for the presumptive identification of streptococci

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term